Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Kaplan

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Transplantation|January 11, 2018
Biomarkers and Kidney Transplant: Time for a New Paradigm?Caroline Johnson, Bruce Kaplan
Nature Clinical Practice. Nephrology|November 13, 2008
The advantage of live-donor kidney transplantation in older recipientsLisa Nanovic, Bruce Kaplan
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
Reliability of Medicare claim forms for outcome studies in kidney transplant recipients: epidemiology in clinical outcome trialsLisa Nanovic, Bruce Kaplan
Journal of the American Society of Nephrology : JASN|October 30, 2021
Need for a Validation Study before Using the Two-Step Algorithm for dd-cfDNA to Screen for Acute RejectionAditi Gupta, Bruce Kaplan
Nature Reviews. Nephrology|September 20, 2016
Transplantation: Utilizing the transcriptome to predict allograft fibrosisAdyr Moss, Bruce Kaplan
Nature Reviews. Nephrology|January 28, 2015
Transplantation: Biomarkers in transplantation—the devil is in the detailMichael Abecassis, Bruce Kaplan
Nature Reviews. Nephrology|November 15, 2016
Caveat emptor: the devil is still in the detailMichael Abecassis, Bruce Kaplan
Nature Reviews. Nephrology|May 28, 2014
Transplantation: CNIs to mTOR inhibitors--effects on allosensitization?Aditi Gupta, Bruce Kaplan
Nature Reviews. Nephrology|March 27, 2009
Transplantation: neural networks for predicting graft survivalBruce Kaplan, Jesse Schold
Transplantation|August 9, 2017
External Validation of Kidney Donor Risk Index Does Not Mitigate Its Basic LimitationsPooja Budhiraja, Bruce Kaplan
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Transplantation|January 11, 2018
Biomarkers and Kidney Transplant: Time for a New Paradigm?Caroline Johnson, Bruce Kaplan
Nature Clinical Practice. Nephrology|November 13, 2008
The advantage of live-donor kidney transplantation in older recipientsLisa Nanovic, Bruce Kaplan
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
Reliability of Medicare claim forms for outcome studies in kidney transplant recipients: epidemiology in clinical outcome trialsLisa Nanovic, Bruce Kaplan
Journal of the American Society of Nephrology : JASN|October 30, 2021
Need for a Validation Study before Using the Two-Step Algorithm for dd-cfDNA to Screen for Acute RejectionAditi Gupta, Bruce Kaplan
Nature Reviews. Nephrology|September 20, 2016
Transplantation: Utilizing the transcriptome to predict allograft fibrosisAdyr Moss, Bruce Kaplan
Nature Reviews. Nephrology|January 28, 2015
Transplantation: Biomarkers in transplantation—the devil is in the detailMichael Abecassis, Bruce Kaplan
Nature Reviews. Nephrology|November 15, 2016
Caveat emptor: the devil is still in the detailMichael Abecassis, Bruce Kaplan
Nature Reviews. Nephrology|May 28, 2014
Transplantation: CNIs to mTOR inhibitors--effects on allosensitization?Aditi Gupta, Bruce Kaplan
Nature Reviews. Nephrology|March 27, 2009
Transplantation: neural networks for predicting graft survivalBruce Kaplan, Jesse Schold
Transplantation|August 9, 2017
External Validation of Kidney Donor Risk Index Does Not Mitigate Its Basic LimitationsPooja Budhiraja, Bruce Kaplan
Pageof 24